Precigen, Inc. (PGEN)
NASDAQ·Healthcare·Biotechnology
$4.76
+0.21%
Mkt Cap $1.34B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+26.2%
Consensus $6.00 vs current $4.76
NASDAQ·Healthcare·Biotechnology
$4.76
+0.21%
Mkt Cap $1.34B
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
+26.2%
Consensus $6.00 vs current $4.76